|
FOR IMMEDIATE RELEASE CONTACT: Matt Hill, NFL, 212-450-2080 Howard Clabo, FedEx, 901-434-7786 NFL.COM
VOTERS SELECT Quarterback DONOVAN MC NABB of the Philadelphia Eagles and running back RUDI JOHNSON of the Cincinnati Bengals are the FedEx Air & Ground NFL Players of the Week for games played on October 24-25, the NFL announced today. McNabb recorded a 114.1 passer rating, completing 28 of 43 passes for 376 yards and four touchdowns in the Eagles’ 34-31 overtime victory over the Cleveland Browns. He threw touchdown passes of two, 10, 39 and 40 yards, and helped set up the game-winning field goal with a 28-yard scramble in OT. Johnson carried 24 times for 119 yards and one touchdown in the Bengals’ 23-10 win over the AFC West-leading Denver Broncos. Johnson scored on a 36-yard run that put the Bengals ahead 20-10 in the third quarter. McNabb and Johnson were selected from among finalists in the air and ground categories through 55,164 fan votes. The other FedEx Express NFL Player of the Week finalists were quarterbacks BYRON LEFTWICH of the Jacksonville Jaguars and PEYTON MANNING of the Indianapolis Colts, while running backs AHMAN GREEN of the Green Bay Packers and PRIEST HOLMES of the Kansas City Chiefs were the other finalists for FedEx Ground NFL Player of the Week. Fans voted for more than their favorite players. The weekly FedEx Air & Ground NFL Players of the Week Awards are also a win for the local community. Along with the player awards, FedEx is awarding Children's Crisis Treatment Center and Cincinnati Children's Hospital, the Children’s Hospital in each winning market, a check for $5,000.The children’s hospitals in the two season-long winner’s markets, announced at this year’s Super Bowl, will be awarded $25,000 each. That means that FedEx will deliver nearly $250,000 to local children’s hospitals around the country in recognition of the FedEx Air & Ground NFL Players of the Week Award winners. FedEx, the premier global provider of transportation, e-commerce and supply-chain management services, is the Official Delivery Service Sponsor of the NFL, Super Bowl and Pro Bowl. Through the weekly FedEx Air and Ground awards, FedEx recognizes those NFL players who represent the same speed, precision and teamwork that their customers have come to expect from the full range of FedEx air, ground, freight and international shipping services. 2004 FEDEX AIR & GROUND NFL PLAYERS OF THE WEEK
FOR IMMEDIATE RELEASE CONTACT: MATT HILL, NFL, 212-450-2080 DAVE DECECCO, PEPSI-COLA, 914-253-2655 NFL.COM
VOTERS SELECT VIKINGS RB MEWELDE MOORE Voters on NFL.com have made their choice. Running back MEWELDE MOORE of the Minnesota Vikings is the PEPSI NFL ROOKIE OF THE WEEK for games played on October 24-25, the NFL announced today. Moore carried 20 times for 138 yards and caught five passes for 30 yards in the Vikings’ 20-3 win over the Tennessee Titans. In his third NFL start, Moore recorded his second consecutive 100-yard rushing game and accounted for 168 of the Vikings 313 total net yards in the contest. More than 28,774 fans voted this week on NFL.com. Moore was selected from among five finalists. The other finalists were wide receiver LARRY FITZGERALD of the Arizona Cardinals, running back KEVIN JONES of the Detroit Lions, defensive end IGOR OLSHANSKY of the San Diego Chargers and kicker JOSH SCOBEE of the Jacksonville Jaguars. After the regular season, five players will be nominated for Pepsi NFL Rookie of the Year honors. Fans can vote for the winner on NFL.com throughout the month of January. The winner will be announced at a press conference at Super Bowl XXXIX in Jacksonville. This is Pepsi’s third year as the official soft drink sponsor of the NFL. 2004 PEPSI NFL ROOKIE OF THE WEEK
Contact : Contact:Seth Rubin Matt Hill Alan Taylor Communications National Football League 212-714-1280 ext. 353 212-450-2080 seth@alantaylor.com hillm@nfl.com AHMAN GREEN’S TOUCHDOWN RUN NAMED WEEK SEVEN "LEVITRAâ (vardenafil HCI) PLAY OF WEEK" NEW YORK—OCTOBER 28, 2004 – Green Bay Packers running back Ahman Green’s 90-yard touchdown run against the Dallas Cowboys has been voted "LEVITRAâ (vardenafil HCI) PLAY OF THE WEEK" for NFL games played October 24-25.Green’s touchdown is now eligible to be selected as the "LEVITRAâ PLAY OF THE YEAR," awarded this February at Super Bowl XXXIX in Jacksonville, Florida. The "LEVITRAâ PLAY OF THE WEEK," which is voted on by fans each week throughout the NFL season from Tuesday at noon ET to Thursday at noon ET on NFL.com, is presented each Thursday and recognizes the single most exciting play that week. Fans who vote at NFL.com each week can also enter for their chance to win a three-day/two-night trip for two to Jacksonville, Florida to attend Super Bowl XXXIX on February 6, 2005, including round-trip airfare and hotel accommodations. With his team leading by the score of 34-10, Green took a Brett Favre handoff, sliced through a hole and outran the Dallas Cowboys defense for a 90-yard score, capping the third-longest run in team history. The Green Bay running back recorded 163 yards on 15 carries and scored twice in the Packers’ 41-20 win. Green edged out Baltimore Ravens cornerback Deion Sanders’ 48-yard interception return for a touchdown against the Buffalo Bills in fan voting on NFL.com. For details and video of this week’s nominees and the results of fan voting, please visit www.NFL.com/playoftheweek In July 2003, Bayer Pharmaceutical Corporation (Bayer) & GlaxoSmithKline(GSK), co-marketers of LEVITRA (vardenafil HCI), a prescription medicine that is used to treat erectile dysfunction (ED), announced their groundbreaking sponsorship of the NFL. 2004 LEVITRAâ PLAY OF THE WEEK Winners
About LEVITRA LEVITRA is a prescription medicine that is used to treat erectile dysfunction (ED). Men taking nitrate drugs, often used to control chest pain (also known as angina), should not take LEVITRA. Men who use alpha blockers, sometimes prescribed for high blood pressure or prostate problems, also should not take LEVITRA. Such combinations could cause blood pressure to drop to an unsafe level. You should not take LEVITRA if your doctor determines that sexual activity poses a health risk for you. Men who experience an erection for more than four hours should seek immediate medical attention. LEVITRA does not protect against sexually transmitted diseases .The starting dose of LEVITRA is 10 mg taken no more than once per day. Your doctor will decide the dose that is right for you. In patients taking certain medications such as ritonavir, indinavir, ketoconazole, itraconazole, and erythromycin, lower doses of LEVITRA are recommended, and time between doses of LEVITRA may need to be extended. In clinical trials, the most commonly reported side effects were headache, flushing, and stuffy or runny nose. LEVITRA is available in 2.5-mg, 5-mg, 10-mg, and 20-mg tablets. About Erectile Dysfunction The consistent or recurrent inability of a man to attain and/or maintain a penile erection sufficient for sexual performance1 – is a common health condition among men that is largely untreated. It is estimated that some degree of ED affects more than one half of all men over the age of 402– 152 million men worldwide3 and 30 million men in the United States alone.4 Despite the high prevalence of sexual problems, nine out of 10 men in the U.S. have not yet sought treatment from a physician.5 1. Jardin A, Wagner G, Khoury S, et al. Recommendations of the 1st International Consultation on Erectile Dysfunction. Co-sponsored by the World Health Organization (WHO), International Consultation on Urological Diseases (ICUD) and Societe Internationale d’Urologie (SIU) and held July 1-3, 1999, Paris. 2000, p. 713. 2. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61. 3. Aytac IA, McKinlay JB, Krane RI. The likely worldwide increase of erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999;84:50-56 4. National Institutes of Health, Consensus Development Conference Statement, December 7-9, 1992. Online data: http://odp.od.nih.gov/consensus/cons/091/091_statement.htm. (accessed 8/26/02). 5. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537-544. About Bayer Pharmaceuticals Corporation Our aim is to discover and manufacture innovative products that will improve human and animal health worldwide. Our products enhance well-being and quality of life by diagnosing, preventing and treating disease. Forward Looking Statement This news release contains forward-looking
statements based on current assumptions and forecasts made by Bayer Group
management. Various known and unknown risks, uncertainties and other factors
could lead to material differences between the actual future results,
financial situation, development or performance of the company and the
estimates given here. These factors include those discussed in Bayer’s
public reports filed with the Frankfurt Stock Exchange and with the U.S.
Securities and Exchange Commission (including its Form 20-F). Bayer assumes
no liability whatsoever to update these forward-looking statements or to
conform them to future events or developments. About GSK GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information about LEVITRA, please visit www.LEVITRA.com. |